Published in JAMA on August 14, 2002
Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome. Clin Pract Epidemiol Ment Health (2005) 0.82
Broken heart: depression in cardiovascular disease. Dialogues Clin Neurosci (2003) 0.79
Universal definition of myocardial infarction. Circulation (2007) 11.69
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol (2011) 4.43
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol (2008) 4.24
Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med (2002) 3.71
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol (2004) 3.43
Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry (2005) 3.41
Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res (2002) 3.27
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user beware. Clin Chem (2012) 3.25
Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem (2009) 3.24
Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol (2004) 3.19
Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation (2010) 3.07
Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol (2003) 2.87
Redefinition of myocardial infarction: prospective evaluation in the community. Circulation (2006) 2.76
Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol (2002) 2.67
Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol (2007) 2.57
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation (2014) 2.50
Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation (2007) 2.47
Preparing the United States for high-sensitivity cardiac troponin assays. J Am Coll Cardiol (2013) 2.46
Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem (2005) 2.43
Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study. Circulation (2002) 2.32
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta (2007) 2.31
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 2.30
High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. Am Heart J (2013) 2.30
Perioperative myocardial infarction. Circulation (2009) 2.30
Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients. Am J Med (2011) 2.29
Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol (2013) 2.28
Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ (2005) 2.23
The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med (2002) 2.22
Comprehensive standardized data definitions for acute coronary syndrome research in emergency departments in Australasia. Emerg Med Australas (2010) 2.19
European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J (2002) 2.11
Interpreting changes in troponin--clinical judgment is essential. Clin Chem (2012) 2.06
How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J (2012) 2.00
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med (2006) 1.96
Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. Clin Chem (2006) 1.94
Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J (2010) 1.88
Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J (2011) 1.86
B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med (2006) 1.85
Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem (2009) 1.82
Quality specifications for B-type natriuretic peptide assays. Clin Chem (2005) 1.81
Development of a clinical prediction rule for 30-day cardiac events in emergency department patients with chest pain and possible acute coronary syndrome. Ann Emerg Med (2011) 1.78
Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med (2003) 1.75
Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*. Crit Care Med (2014) 1.75
Practical implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the emergency department. Ann Emerg Med (2005) 1.72
Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med (2005) 1.70
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation (2007) 1.69
The quantification of infarct size. J Am Coll Cardiol (2004) 1.67
History of depression and survival after acute myocardial infarction. Psychosom Med (2009) 1.65
Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet (2003) 1.64
Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med (2004) 1.64
Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem (2008) 1.62
Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun (2003) 1.60
Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem (2005) 1.58
A simple method to identify sleep apnea using Holter recordings. J Cardiovasc Electrophysiol (2003) 1.56
Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation. Eur Heart J (2005) 1.54
Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem (2010) 1.52
Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with acute gastrointestinal bleeding. Crit Care Med (2009) 1.48
Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv (2008) 1.45
Myocardial Dysfunction in Severe Sepsis and Septic Shock: No Correlation With Inflammatory Cytokines in Real-life Clinical Setting. Chest (2015) 1.45
Thirty-day rehospitalizations after acute myocardial infarction: a cohort study. Ann Intern Med (2012) 1.45
Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol (2005) 1.43
Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community. Arterioscler Thromb Vasc Biol (2006) 1.43
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J (2011) 1.42
Troponin T levels and infarct size by SPECT myocardial perfusion imaging. JACC Cardiovasc Imaging (2011) 1.41
Troponin elevations after electroconvulsive therapy: the need for caution. Am J Med (2011) 1.41
Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. J Cardiopulm Rehabil (2003) 1.41
Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Arch Gen Psychiatry (2009) 1.40
Interpreting biomarkers during percutaneous coronary intervention: the need to reevaluate our approach. Arch Intern Med (2012) 1.40
Telephone-based coping skills training for patients awaiting lung transplantation. J Consult Clin Psychol (2006) 1.33
Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients. Am Heart J (2010) 1.27
Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry (2006) 1.21
Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. J Clin Oncol (2004) 1.16
Depression and coronary heart disease in women with diabetes. Psychosom Med (2003) 1.15
Third universal definition of myocardial infarction. Glob Heart (2012) 1.14
Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation (2008) 1.13
Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol (2013) 1.13
Third universal definition of myocardial infarction. Nat Rev Cardiol (2012) 1.12
2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay. Clin Chem (2010) 1.11
Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc (2004) 1.10
Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. Psychosom Med (2004) 1.10